Principal Technologies Inc. Stock OTC Markets

PTEKF

CA74260Q1028

Biotechnology & Medical Research

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

06:29am	Principal Technologies Closes C$312,000 Private Placement Financing	MT
Jul. 16	Principal Technologies to Raise C$312,000 in Third Financing Round	MT

Valuation: Principal Technologies Inc.

Market Cap	16.45M 11.68M 10.26M 9.54M 8.76M 1.13B 16.71M 113M 44.27M 553M 43.85M 42.91M 1.91B	P/E 2024 *	-	P/E 2025	-2x
Enterprise Value	15.45M 10.97M 9.63M 8.96M 8.22M 1.06B 15.69M 106M 41.57M 519M 41.18M 40.29M 1.8B	EV / Sales 2024	7,172,726x	EV / Sales 2025	25,290,400x
Free-Float	66.64%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Latest news : Principal Technologies Inc.

06:29am	Principal Technologies Closes C$312,000 Private Placement Financing	MT
Jul. 16	Principal Technologies to Raise C$312,000 in Third Financing Round	MT
Jul. 10	Principal Technologies Raises C$1.1 Million in a Private Placement; Settles C$1.2 Million of Debts	MT
Jul. 08	Principal Technologies Inc. announced that it has received CAD 1.100014 million in funding	CI
Jun. 26	Principal Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2026	CI
Jun. 02	Principal Technologies Inc. announced that it expects to receive CAD 1.1015 million in funding	CI
Mar. 27	Principal Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2026	CI
Dec. 30	Principal Technologies Inc. Reports Earnings Results for the First Quarter Ended October 31, 2025	CI
Dec. 15	Principal Technologies closes private placement financing	RE
Dec. 14	Principal Technologies Inc. announced that it has received CAD 1.2 million in funding	CI
Nov. 29	Principal Technologies Inc. Reports Earnings Results for the Full Year Ended July 31, 2025	CI
Nov. 28	Principal Technologies Inc. Auditor Raises 'Going Concern' Doubt	CI
Nov. 28	Principal Technologies Announces Private Placement Financing	MT

More news

Press Releases: Principal Technologies Inc.

Jul. 24	PRINCIPAL TECHNOLOGIES CLOSES PRIVATE PLACEMENT FINANCING	AQ
Jul. 16	PRINCIPAL TECHNOLOGIES ANNOUNCES PRIVATE PLACEMENT FINANCING IN CONNECTION WITH OXFORD LICENCE AGREEMENT	AQ
Jul. 09	PRINCIPAL TECHNOLOGIES CLOSES PRIVATE PLACEMENT FINANCING AND DEBT SETTLEMENT TRANSACTIONS	AQ
Jun. 03	PRINCIPAL TECHNOLOGIES ANNOUNCES PRIVATE PLACEMENT FINANCING AND DEBT SETTLEMENT TRANSACTIONS	AQ
Dec. 15	PRINCIPAL TECHNOLOGIES CLOSES PRIVATE PLACEMENT FINANCING	AQ

More press releases

Managers and Directors: Principal Technologies Inc.

Manager	Title	Age	Since
Gerald Trent CEO	Chief Executive Officer	47	2021-08-03
Peter McKeown DFI	Director of Finance/CFO	70	2023-03-05

Director	Title	Age	Since
Leopold Specht BRD	Director/Board Member	70	2021-08-03
Alfred von Liechtenstein CHM	Chairman	55	-
Gerald Trent BRD	Director/Board Member	47	2021-08-03

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PRINCIPAL TECHNOLOGIES INC.	-.--%	-.--%	-	-	11.68M
LONZA GROUP AG	+1.33%	-1.66%	-1.70%	+10.81%	46.86B
REVOLUTION MEDICINES, INC.	+2.03%	+1.65%	+399.22%	+647.65%	40.23B
BEONE MEDICINES AG	+0.54%	+4.45%	+11.81%	+60.81%	36.23B
IQVIA HOLDINGS INC.	+1.07%	+0.87%	+4.46%	-10.31%	34.72B
CELLTRION, INC.	+3.14%	+1.02%	+4.76%	+43.00%	27.89B
MEDPACE HOLDINGS, INC.	-0.06%	+11.84%	+34.39%	+134.44%	16.79B
ASCENDIS PHARMA A/S	+1.05%	-2.74%	-	-	16.74B
EUROFINS SCIENTIFIC SE	+0.15%	-6.53%	+1.59%	+7.02%	13.12B
ICON PUBLIC LIMITED COMPANY	+1.71%	-2.49%	-11.36%	-34.51%	12.7B
Average	+1.08%	+0.83%	+55.40%	+107.36%	27.25B
Weighted average by Cap.	+1.31%	+0.91%	+75.04%	+137.90%

See all sector performances

Principal Technologies Inc. is a Canada-based healthcare acquisition company. The Company is engaged in building a diverse portfolio of investments in healthcare technology companies with a focus on those with global distribution potential which have intellectual property capable of enhancing medical treatment quality, cost efficiency, optimization of the patient pathway, and implementation of point of care technologies. The Company operates through the health-care technology segment, including the project management of international scale clinical studies primarily related to medical device technologies. Its subsidiaries include Principal Technologies Capital Management GmbH and E&E CRO Consulting GmbH.

Employees

Sector

Biotechnology & Medical Research

More about the company

Income Statement and Estimates

More financial data

As early as today, start finding the best investment opportunities!

Maximize my profits

3 years	0		0.27
5 years	0		0.27
10 years	0		0.27

	2024	2025
Net sales	0.66 0.47 0.41 0.39 0.35 45.41 0.67 4.57 1.79 22.32 1.77 1.73 77.18	0.37 0.26 0.23 0.21 0.2 25.33 0.38 2.55 1 12.45 0.99 0.97 43.06
Net income	-1.62M -1.15M -1.01M -937K -860K -110M -1.64M -11.12M -4.35M -54.3M -4.31M -4.21M -188M	-4.24M -3.01M -2.64M -2.46M -2.25M -290M -4.3M -29.17M -11.4M -142M -11.29M -11.05M -492M
Net Debt	-767K -545K -479K -445K -408K -52.48M -779K -5.29M -2.06M -25.8M -2.05M -2M -89.2M	-1M -712K -626K -582K -534K -68.59M -1.02M -6.91M -2.7M -33.72M -2.67M -2.62M -117M

Principal Technologies Inc. Stock OTC Markets

Stocks

PTEKF

CA74260Q1028

Biotechnology & Medical Research

Valuation: Principal Technologies Inc.

Latest news : Principal Technologies Inc.

Press Releases: Principal Technologies Inc.

Course Extremes

Managers and Directors: Principal Technologies Inc.

Other Biotechnology & Medical Research

Financials

Company Profile

Income Statement and Estimates